Quantum Innovations funding news – Medtech Startup Quantum Innovations Secures €9.4 Million in Second Round Funding

The group under the direction of Grzegorz Suwalski, M.D., PhD, has created the first sensor technology in history for use in transplantation and organ monitoring during surgery.

Through the use of their Heart Sense technology, real-time ECG monitoring is possible right from the surface of a beating heart. Heart Guard technology additionally monitors tissue metabolism, even while the heart is stopped for cardiac surgery.

The money received in the current financing round will be put towards starting their own production line, carrying out clinical and regulatory trials, being certified, and breaking into important international markets.

After a century of tremendous advancements and developments, cardiac surgery is without a doubt one of the medical specialties that is growing the fastest.

This encompasses not only the initial heart transplant but also the development of vascular sutures, coronary artery bypass grafts (CABG), heart valve replacements, and several minimally invasive techniques as transcatheter aortic valve implantation (TAVI).

Read also - Qblox funding news – Quantum startup Qblox Secures $26Million in Series A Round Funding

Cardiovascular disorders continue to be one of the two main causes of death in affluent nations notwithstanding these advancements. The most recent World Heart Report 2023 states that about 20.5 million fatalities globally, or 30% of all deaths, are attributable to cardiovascular diseases, which affect over half a billion people.

A recent report by iData Research also presents alarming data, estimating that 900,000 cardiac procedures are conducted annually in the United States, and that figure is predicted to increase to 1.3 million by 2029.

The advancement of medical technologies lowers mortality and complications and boosts the success rate of cardiothoracic procedures considerably. Extreme precision and constant monitoring are necessary during surgeries, particularly those involving internal organs. Such skills are not offered by any of the instruments or equipment that is currently in use. To close this gap, the Polish business Quantum Innovations has created technology.

Grzegorz Suwalski, Founder and CEO of Quantum Innovations said, “Acquiring new and previously inaccessible precise signals from the organs and body parts undergoing surgery pushes the boundaries of our knowledge. Overcoming these barriers opens up prospects for improving medical procedures. Thus, Heart Sense technology makes it possible to examine the ECG of the operated heart, in any of its positions, from any of its walls, directly from its surface. Heart Guard technology, on the other hand, monitors the metabolism-dependent acidification of the heart. Studies indicate that using this data can help cardiac teams overcome knowledge gaps and prevent dangerous complications and fatalities in patients,”.

The Quantum Innovations team is presently raising funds to build and set up a clean-room production line. They will also use this money to undertake clinical trials on humans and obtain the appropriate certifications that will help get the product onto international markets.

Piotr Woliński, President of Vinci S.A., which manages the Vinci IQ ASI fund said, “We were convinced to invest primarily by the groundbreaking product and technology, as well as the practical experience of the team. The solutions proposed by QI address an unmet need in clinical practice during cardiothoracic surgeries. Introducing these solutions into medical standards has the potential to significantly reduce complications and perioperative mortality associated with heart surgeries. Investments in medical technologies like QI fit perfectly with our fund’s mission of supporting sustainable development,”.

About Quantum

Quantum was founded with the goal of developing solutions that address specific issues in cardiology, pulmonary medicine, and cardiac surgery.

The main goal of quantum devices is to make invasive cardiac surgery procedures carried out in global cardiac surgical centres safer. As assisting these procedures will have the biggest influence on public health, they first concentrate on those with the highest volume.